HomeRUBICON • NSE
add
Rubicon Research Ltd
Previous close
₹655.65
Day range
₹655.95 - ₹692.50
Year range
₹570.75 - ₹754.80
Market cap
113.17B INR
Avg Volume
471.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 4.12B | 39.19% |
Operating expense | 2.03B | 24.29% |
Net income | 538.52M | 56.19% |
Net profit margin | 13.07 | 12.19% |
Earnings per share | 3.47 | — |
EBITDA | 976.82M | 48.90% |
Effective tax rate | 24.90% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.51B | 90.52% |
Total assets | 17.82B | — |
Total liabilities | 11.35B | — |
Total equity | 6.47B | — |
Shares outstanding | 154.30M | — |
Price to book | 15.63 | — |
Return on assets | 12.02% | — |
Return on capital | 17.38% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 538.52M | 56.19% |
Cash from operations | 605.38M | 113.79% |
Cash from investing | -211.35M | -28.03% |
Cash from financing | 10.23M | 105.42% |
Net change in cash | 394.74M | 838.52% |
Free cash flow | 388.65M | — |
About
Rubicon Research is an Indian pharmaceutical company located in Mumbai.
The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, a manufacturing plant located in Ambernath, India, and a regulatory office in Plainsboro, US. Wikipedia
Founded
1999
Website
Employees
1,141
